Ipamorelin 10MG $59
Peptides · CAS 170851-70-4 ≥99% Purity · HPLC verified

Ipamorelin 10MG

Research-grade Ipamorelin peptide. ≥99% purity, third-party verified via HPLC. For research and laboratory use only.

Save more · Bundle
1 vial · Single
Standard pricing
$59.00
$59.00 each
Save 10%
2 vials · Stock up
You save $11.80
$106.20
$118.00
★ Most popular
3 vials · Best value
You save $26.55
$150.45
$177.00
1
≥99% PurityHPLC verified Lab testedHPLC + MS Same-day shipOrder by 2pm PT
99.5% Purity
Certificate of Analysis
Third-party verified by HPLC & mass spectrometry
View COA
Curated picks

Frequently researched together

View all →
Identity

Compound information

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue first developed by Novo Nordisk in 1998. It is a selective agonist of the ghrelin/GHS-R1a receptor, studied for its release of growth hormone in pituitary cell preparations without significant cortisol or prolactin elevation.

CAS Number 170851-70-4
Molecular Formula C38H49N9O5
Molecular Weight 711.86 g/mol
Amino Acid Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Half-Life ~2 hours (intravenous, rat models)
Source Synthetic peptide
Purity 99.5% (HPLC verified)
Form Lyophilized powder
Solubility Soluble in water, bacteriostatic water
Storage

Stability information

Long-term
−20°C
Lyophilized powder, sealed
Reconstituted
2–8°C
Up to 30 days when refrigerated
Shipping
Room temp
Stable in transit, lyophilized
Protection
Light · Moisture
Store sealed, away from light
Background

About this compound

Ipamorelin is a pentapeptide and selective ghrelin receptor (GHS-R) agonist, studied for its role in growth hormone secretagogue pathways. Known for selectivity over other endocrine axes in laboratory models. Each vial contains 10mg lyophilized powder at ≥99% purity.

Specifications:

  • Purity: ≥99% (HPLC verified)
  • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
  • Form: Lyophilized powder
  • Storage: -20°C (long-term), 2-8°C (reconstituted)
  • Certificate of Analysis available

For research and laboratory use only. Not for human consumption.

Bibliography

Sources & references

01
European Journal of Endocrinology · 1998
Ipamorelin, the first selective growth hormone secretagogue
Raun K, Hansen BS, Johansen NL, et al.
Original characterization of Ipamorelin selectivity in rodent and swine pituitary cell preparations.
View source →
02
International Journal of Molecular Sciences · 2014
The growth hormone secretagogue receptor: its intracellular signaling and regulation
Yin Y, Li Y, Zhang W
Review of GHS-R1a signaling pathways relevant to ghrelin receptor agonists.
View source →
03
Physiological Reviews · 2005
Ghrelin: structure and function
Kojima M, Kangawa K
Foundational review of ghrelin/GHS-R receptor pharmacology.
View source →
04
European Journal of Endocrinology · 1999
Comparison of ipamorelin with growth hormone-releasing peptide-6 on growth hormone secretion
Hansen BS, Raun K, Nielsen KK, et al.
Comparative GH secretion study in rodent and swine models.
View source →
More

Related products

View all →